Download Files:
PARG-IN-4
$650 – $5,450
Products Details
Product Description
– PARG-IN-4 (Formula (A)) is an orally active and cell-permeable PARG inhibitor. PARG-IN-4 effectively inhibits tumor growth in mouse models. PARG-IN-4 can be used in cancer research[1].
Web ID
– HY-156881
Shipping
– Room temperature
Molecular Formula
– C20H25F2N7O2S2
References
– [1]Paul A Barsanti, et al. Piperazine substituted indazole compounds as inhibitors of parg. Patent WO2023183850A1.
CAS Number
– 2988890-20-4
Molecular Weight
– 497.59
SMILES
– CC1(CC1)NS(=O)(C2=CC(N3C[C@@H](N[C@H](C3)C)C)=C(C=NN4C5=NN=C(C(F)F)S5)C4=C2)=O
Clinical Information
– Phase 4
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Poly(ADP-ribose) Glycohydrolase (PARG)
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
